Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells
April 17th, 2015 by Daniel I. Benjamin, Daniel S. Li, Wallace Lowe, Timothy Heuer, George Kemble and Daniel K. Nomura
ACS Chemical Biology
DOI: 10.1021/acschembio.5b00240